Skip to main content

Anti-Aging Research: Science, not Hype

Last updated May 2023
Q: "How is aging a disease?"

A: It's a dynamic system that veers away from its homeostasis (normal equilibrium point): hence a form of slow-progressing illness. Labeling it as 'natural' is a surrender to our traditional state of ignorance and powerlessness, which fortunately is beginning to be changed!

Aging is "normal" only from the point of view of the "selfish gene", for whom the body is a disposable carrier. Individuals organisms - for whom self-preservation has a different meaning than for genes - have received scant help from evolution... with rare exceptions such as the T. dohrnii jellyfish (which I discuss here)... but now the time has finally arrived for our rational design to remedy some of the cellular flaws that evolution never bothered to correct!

 

The above is my standard answer to an oft-asked question.

The science of aging is by all evidence very misunderstood by the general public.  Hype, misinformation and unquestioned assumptions often prevail, unfortunately.

Aging as a systemic breakdown of the body, rather than a series of isolated events and conditions.

This 2013 diagram from NIH is a good way to jump-start contemplating the big picture:

The diagram originates from the Cell journal: The Hallmarks of Aging  

Telomere shortening is perhaps the one most talked about - but just one of several processes.  As stated in the above paper:
Each hallmark should ideally fulfill the following criteria:
(1) it should manifest during normal aging;
(2) its experimental aggravation should accelerate aging; and
(3) its experimental amelioration should retard the normal aging process and hence increase healthy lifespan. This set of ideal requisites is met to varying degrees by the proposed hallmarks

The Business Side

That was a little science background for starters - but how about financial/business considerations?

Here’s a fascinating story about a brilliant 23 y.o. woman, Laura Deming, an MIT graduate who raised $22 million in 2017!  She formed  Longevity Fund, an early-stage venture capital company currently managing $37 millions to invest in anti-aging companies.

Fortunately, both academic researchers and companies are beginning to advance the relatively new field of anti-aging as a subject of systematic scientific pursuit, the "project Apollo" of our times.

You might have heard about the $300 M invested in Unity Biotechnology; the investors include Jeff Bezos (Amazon) and Peter Thiel (Paypal's co-founder.)

Also in recent news was the growing hub of anti-aging startups in the Boston area.  And not just Boston; the longevity companies in the San Francisco area, too, among other places.  In particular, Calico, Google's research on aging and age-related diseases, founded in 2013.  Forbes magazine, in a March 2019 article, reviews opportunities for biotech companies in the Anti-Aging market.

Explosive growth in many directions: even crowdfunding of age-related research.

Anti-aging science is well aligned with my personal research interest in Systems Biology, and in particular Interactomics: I expand on Interactomics and the future of medicine in a separate blog entry. 

Who's Who in the Anti-Aging Field?

(Alphabetic listing.  More entries will be progressively added as I review them.)

AgeX Therapeutics, San Francisco area, CA
Development and commercialization of novel therapeutics targeting human aging.  Its VP of New Technology Discovery is the iconic Aubrey de Grey (a name synonymous with Anti-Aging research and advocacy.)

Altos Labs, San Francisco area and San Diego, CA, as well as Cambridge, UK
See my separate entry
 

BioAge, San Francisco area, CA
Working on a broad pipeline of therapies to extend human healthspan and lifespan

Buck Institute for Research on Aging, Novato, CA.
The world’s first biomedical research institution devoted solely to research on aging.  In operation since 1999, it has a fairly large faculty in its own sizable campus a little north of San Francisco.  They follow many directions, and their website mentions 10 focus areas.

Calico Life Sciences,  South San Francisco, CA
Google's research on aging and age-related diseases, founded in 2013.  In an extended collaboration with the Broad Institute (MIT and Harvard.)

Celularity, Florham Park, NJ
It has demonstrated that placental-derived stem cells given to animals can extend life up to 30 percent. Celularity now aims to make this approach viable in humans. (Source: blog entry from the company's co-founder Peter Diamandis, the founder of the well-known XPRIZE Foundation.)

FightAging.org, something of an information clearinghouse on anti-aging research.

Human Longevity, San Diego, CA
Genomics and cell therapy-based diagnostic and therapeutic company focused on extending the healthy human lifespan 

InSilico Medicine, Hong Kong (also with a strong Russian collaboration.)
AI for drug discovery, biomarker development & aging research.  They sponsor the Aging Research & Drug Discovery meetings.

Juvena Therapeutics,  Palo Alto, CA
Biopharma startup developing protein-based tissue rejuvenation.

Juvenescence, San Diego, CA
Developing therapies to treat diseases of aging and increase human longevity.  Their website has a good timeline of the major breakthroughs in aging research

Lifespan.io (LEAF) New York City, NY
Life Extension Advocacy Foundation. A non-profit involved in fundraising, science journalism and running the annual conference Ending Age-Related Diseases.

 MDI Biological Laboratory, Salisbury Cove, ME
Non-profit biomedical research institution with a research program in regenerative and aging biology and medicine.

OpenCures, Novato, CA
[I worked here as the CTO between June and Nov. 2020, before relocating to GSK.  During my tenure, the company started making use of the game-changing technology of graph databases, which I discuss in this entry.]
A start-up focused on using community research and individuals’ health data to discover and develop interventions in age-related disease.  Started by the co-founder of the SENS Research Foundation, Kevin Perrott.  A main focus is metabolomics - involving the measurements of a large number of biomarkers carried out by Prodrome Sciences.

Regenerative Medicine Foundation, Wellington, FL
Conferences, Patient Advocacy, Policy, Outreach and Networking

SENS Research Foundation, Mountain View, CA
A non-profit supporting  research projects at universities and institutes, with a focus on a damage-repair paradigm for treating the diseases of aging.  It co-sponsors the large annual international conference "Undoing Aging", and was co-founded in 2009 by Aubrey de Grey.

Termis : Tissue Engineering and Regenerative Medicine International Society 
A very international nonprofit founded in 2006 

UNITY Biotechnology, South San Francisco, CA
Their initial focus is on creating "senolytic" medicines to selectively eliminate senescent cells and hopefully treat age-related diseases.
Investors include Jeff Bezos (Amazon) and Peter Thiel (Paypal's co-founder.)

Wake Forest Institute for Regenerative Medicine, Winston-Salem, North Carolina
It has been engineering laboratory-grown organs that were successfully implanted into humans.

Additional entries (142 companies as of Apr. 2021) in this spreadsheet from AgingBiotech.info


Other News Sources

Longevity Technology


Events / Conferences

I've been blown away by the galloping pace of recent developments, and the rapid-fire formation of startups to explore promising directions.

As a result of Covid, some of the conference organizers finally added remote-attendance options, which makes it infinitely easier to attend them.  Hopefully, the remote options will remain in place.

Here are some conferences that I attended myself, or that I know of:

Aging Research & Drug Discovery meetings.  Sponsored by InSilico Medicine.

American Aging Association meetings.  Annual.  In its 49th year as of the next meeting.

BAAM: Bay Area Aging Meetings.  Twice/year.  Hosted by UC Berkeley, Stanford, UCSF, Buck Institute for Research on Aging, and the Gladstone Institutes.

Ending Age-Related Diseases.  Sponsored by Lifespan.io
I attended the latest one (Aug. 2022), and was impressed.

Metabesity.   " ‘Metabesity’ is a term coined by G Alexander Fleming MD to reference the constellation of interconnected diseases with metabolic roots. Targeting these metabolic underpinnings could be a productive approach to delaying, or even preventing, many or most of the chronic diseases of aging." (source)
I attended the latest one (Oct. 2022): another fine conference!

Undoing Aging.  Large annual international conference.

Additional entries in this spreadsheet from AgingBiotech.info 


Dear conference organizers, the option of remote access to conferences OUGHT TO be given, no matter what, pandemic or not!  Conferences are meant to bring people together in different combinations, to reshuffle ideas, etc.

A conference that's only onsite is basically saying: "if you live far away, or don't have the budget or the time or the option to travel, get lost!"

The net result is cliques of people talking to each other, rather than a true global mixing!


On Social Media

My professional/scientific profile on Facebook

 

Facebook pages by organizations: 

Open Cures  (I worked here in 2020)

SENS Research Foundation

 

Facebook groups:

Ending aging: SENS, SENS Foundation, Aubrey de Grey
Informal community discussion of the work of Aubrey de Grey and SENS Research Foundation (SRF)

 

Review of Facebook groups:

10 Best Longevity Facebook Groups


Venture Funds

fightaging.org lists the following Venture Funds:

Other Funding Sources

Labels:

Comments

  1. WalticularJanuary 27, 2022 at 11:48 AM

    Firstly, it is a mistake to think that homeostasis equals optimum. Everything about us is a compromise established largely by previous, potentially-irrelevant environmental pressures on evolution. This includes average and maximum intrinsic natural (that is, barring accidents or infections) lifespan,
    Secondly, it increasingly appears that there is indeed a natural minimum rate of biological aging, which is subject to acceleration, but cannot be halted or reversed, except by interventions that reset the balance of epigenetically-mediated genetic expression. That expression is genetically coded, and intrinsic systemic bio-aging is essentially an extension of what we commonly call 'development', which is just an early phase of biological aging. Biological aging is 'natural', and calling it that is not "...a surrender to our traditional state of ignorance and powerlessness", but rather an acknowledgement that nature has sentenced us to destructive aging and death for its own purposes. In our time, we will earn a partial or perhaps total reprieve from this sentence.

    ReplyDelete

Post a Comment

Popular posts from this blog

Discussing Neuroscience with ChatGPT

UPDATED Apr. 2023 - I'm excited by ChatGPT 's possibilities in terms of facilitating advanced learning .  For example, I got enlightening answers to questions that I had confronted when I first studied neuroscience.  The examples below are taken from a very recent session I had with ChatGPT (mid Jan. 2023.) Source: https://neurosciencestuff.tumblr.com In case you're not familiar with ChatGPT, it's a very sophisticated "chatbot" - though, if you call it that way, it'll correct you!  'I am not a "chatbot", I am a language model, a sophisticated type of AI algorithm trained on vast amounts of text data to generate human-like text'. For a high-level explanation of how ChatGPT actually works - which also gives immense insight into its weaknesses, there's an excellent late Jan. 2023 talk by Stephen Wolfram, the brilliant author of the Mathematica software and of Wolfram Alpha , a product that could be combined with ChatGPT to imp...
1 comment
Read more

Using Schema in Graph Databases such as Neo4j

UPDATED Feb. 2024 - Graph databases have an easygoing laissez-faire attitude: "express yourself (almost) however you want"... By contrast, relational databases come across with an attitude like a micro-manager:  "my way or the highway"... Is there a way to take the best of both worlds and distance oneself from their respective excesses, as best suited for one's needs?  A way to marry the flexibility of Graph Databases and the discipline of Relational Databases? This article is part 5 of a growing,  ongoing  series  on Graph Databases and Neo4j Let's Get Concrete Consider a simple scenario with scientific data such as the Sample, Experiment, Study, Run Result , where Samples are used in Experiments, and where Experiments are part of Studies and produce Run Results.  That’s all very easy and intuitive to represent and store in a Labeled Graph Database such as Neo4j .   For example, a rough draft might go like this:   The “labels” (b...
Post a Comment
Read more

Graph Databases (Neo4j) - a revolution in modeling the real world!

UPDATED Oct. 2023 - I was "married" to Relational Databases for many years... and it was a good "relationship" full of love and productivity - but SOMETHING WAS MISSING! Let me backtrack.   In college, I got a hint of the "pre-relational database" days...  Mercifully, that was largely before my time, but  - primarily through a class - I got a taste of what the world was like before relational databases.  It's an understatement to say: YUCK! Gratitude for the power and convenience of Relational Databases and SQL - and relief at having narrowly averted life before it! - made me an instant mega-fan of that technology.  And for many years I held various jobs that, directly or indirectly, made use of MySQL and other relational databases - whether as a Database Administrator, Full-Stack Developer, Data Scientist, CTO or various other roles. UPDATE: This article is now part 1 of a growing, ongoing series on Graph Databases and Neo4j But ther...
Post a Comment
Read more

What are Graph Databases - and Why Should I Care?? : "Graph Databases for Poets"

  This is a very gentle introduction to the subject.  The subtitle is inspired by university courses such as "Physics for Poets"!  (if you're technically inclined, there's an alternate article for you.) It has been said that "The language of physics (or of God) is math".  On a similar note, it could be said that: The language of the biological world - or of any subject or endeavor involving complexity - is networks ('meshes') What is a network?  Think of  it as the familiar 'friends of friends' diagram from social media. Everywhere one turns in biology, there's a network – at the cellular level, tissue level, organ level, ecosystem level.  The weather and other earth systems are networks.  Human societal organization is a network.  Electrical circuits, the Internet, our own brains...  Networks are everywhere! What can we do with networks, to better understand the world around us, or to create something that we need? Broadly ...
Post a Comment
Read more

Using Neo4j with Python : the Open-Source Library "NeoAccess"

So, you want to build a python app or Jupyter notebook to utilize Neo4j, but aren't too keen on coding a lot of string manipulation to programmatic create ad-hoc Cypher queries?   You're in the right place: the NeoAccess library can do take care of all that, sparing you from lengthy, error-prone development that requires substantial graph-database and software-development expertise! This article is part 4 of a growing,  ongoing  series  on Graph Databases and Neo4j   "NeoAccess" is the bottom layer of the technology stack provided by the BrainAnnex open-source project .  All layers are very modular, and the NeoAccess library may also be used by itself , entirely separately from the rest of the technology stack.  (A diagram of the full stack is shown later in this article.) NeoAccess interacts with the Neo4j Python driver , which is provided by the Neo4j company, to access the database from Python; the API to access that driver is very p...
Post a Comment
Read more

Visualization of Graph Databases Using Cytoscape.js

(UPDATED APR. 2024)   I have ample evidence from multiple sources that there are strong unmet needs in the area of visualization of graph databases. And whenever there's a vacuum, vendors circle like vultures - with incomplete, non-customizable, and at times ridiculously expensive, closed-box proprietary solutions.   Fortunately, coming to the rescue is the awesome open-source cytoscape.js library ,  an offshoot of the "Cytoscape" project of the  Institute for Systems Biology , a project with a long history that goes back to 2002. One can do amazing custom solutions, relatively easily, when one combines this Cytoscape library with:   1) a front-end framework such as Vue.js   2) backend libraries (for example in python) to prepare and serve the data   For example, a while back I created a visualizer for networks of chemical reactions, for another open-source project I lead ( life123.science )   This visualizer will look and feel generally ...
Post a Comment
Read more

Neo4j Sandbox Tutorial : try Neo4j and learn Cypher - free and easy!

So, you have an itch to test-drive Neo4j and its Cypher query language.  Maybe you want to learn it, or evaluate it, or introduce colleagues/clients to it.  And you wish for: fast, simple and free! Well, good news: the Neo4j company kindly provides a free, short-term hosted solution called "the Neo4j sandbox" .  Extremely easy to set up and use! This article is part 2 of a growing, ongoing series on Graph Databases and Neo4j Register (free) for the Neo4j "Sandbox" Go to sandbox.neo4j.com , and register with a working email and a password.  That's it! Note that this same email/password will also let you into the Neo4j Community Forums and Support ; the same login for all: very convenient! Launch your instance - blank or pre-populated After registering, go to  sandbox.neo4j.com  , and follow the steps in the diagram below (the choices might differ, but the "Blank Sandbox" should always be there): Too good to be true?  Is there...
Post a Comment
Read more

Neo4j & Cypher Tutorial : Getting Started with a Graph Database and its Query Language

You have a general idea of what Graph Databases - and Neo4j in particular - are...  But how to get started?  Read on! This article is part 3 of a growing,  ongoing  series  on Graph Databases and Neo4j   If you're new to graph databases, please check out part 1 for an intro and motivation about them.  There, we discussed an example about an extremely simple database involving actors, movies and directors...  and saw how easy the Cypher query language makes it to answer questions such as "which directors have worked with Tom Hanks in 2016" - questions that, when done with relational databases and SQL, turn into a monster of a query and an overly-complicated data model involving a whopping 5 tables! In this tutorial, we will actually carry out that query - and get acquainted with Cypher and the Neo4j browser interface in the process.  This is the dataset we'll be constructing: Get the database in place If you don't already have a datab...
Post a Comment
Read more

Full-Text Search with the Neo4j Graph Database

(UPDATED May 2024)   Now that we have discussed a full technology stack based on Neo4j (or other graph databases), and that we a design and implementation available from the open-source project BrainAnnex.org  , what next?  What shall we build on top? Well, how about  Full-Text Search ?  This article is part of a growing, ongoing series on Graph Databases and Neo4j Full-Text Searching/Indexing The Brain Annex open-source project includes an implementation of a design that uses the convenient services of its Schema Layer , to provide indexing of word-based documents using Neo4j. The python class FullTextIndexing ( source code ) provides the necessary methods, and it can parse both plain-text and HTML documents (for example, used in "formatted notes"); parsing of PDF files and other formats will be added at a later date. No grammatical analysis ( stemming or lemmatizing ) is done on the text.  However, a long list of common word ("stop ...
Post a Comment
Read more